NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
59 hedge funds and large institutions have $155M invested in NKGen Biotech, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 10 closing their positions.
Holders
59
Holders Change
+6
Holders Change %
+11.32%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
13
Reduced
6
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SIM
1
Sandia Investment Management
Boston,
Massachusetts
|
$6.23M |
| 2 |
CIM
2
Cowen Investment Management
New York
|
$5.47M |
| 3 |
3
Jane Street
New York
|
$4.98M |
| 4 |
CAC
4
Cowen and Company
New York
|
$3.62M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$4.33M |
